Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

    April 2020 in “ Journal of Cosmetic Dermatology
    John D. McCoy, Carlos Gustavo Wambier, Sergio Vano-Galvan, Jerry Shapiro, Rodney Sinclair, Paulo Müller Ramos, Kenneth Washenik, Murilo Ferreira de Andrade, Sabina Herrera, Andy Goren
    Image of study
    TLDR Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
    The article suggests that genetic variations in the androgen receptor may be a contributing factor to the racial disparities in COVID-19 deaths. The authors propose that androgens may be implicated in COVID-19 disease severity and that special attention may need to be given to African Americans infected with the virus. The article suggests that anti-androgens or androgen modulating drugs may be beneficial in treating COVID-19, particularly if androgen sensitivity can be confirmed as a predisposition to SARS-Cov-2 disease severity.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results